Resumen
This review covers the efficacy, side effects, and toxicity of various classes of antidepressants: tricyclics (TCAs), monoamine oxidase inhibitors (MAOIs), and second generation antidepressants including the selective inhibitors of serotonin reuptake (SSRIs). Also reviewed are newer drugs such as moclobemide, a reversible inhibitor of monoamine oxidase (RIMA), and venlafaxine, a drug that inhibits the uptake of both norepinephrine and serotonin (similar in this respect to a number of the TCAs) but has a side‐effect profile more like that of the SSRIs. Depression 2:1–19 (1994). © 1994 Wiley‐Liss, Inc.
| Idioma original | English (US) |
|---|---|
| Páginas (desde-hasta) | 1-19 |
| Número de páginas | 19 |
| Publicación | Depression |
| Volumen | 2 |
| N.º | 1 |
| DOI | |
| Estado | Published - 1994 |
ASJC Scopus subject areas
- Psychiatry and Mental health
Huella
Profundice en los temas de investigación de 'Antidepressant drugs'. En conjunto forman una huella única.Citar esto
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS